Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	306.03M +42.1%
Revenue (ttm)	89.71M +126.5%
Net Income	2.21M
EPS	0.02
Shares Out	100.01M
PE Ratio	129.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,706
Open	3.200
Previous Close	3.300
Day's Range	3.060 - 3.300
52-Week Range	2.030 - 4.980
Beta	0.68
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 32
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 62.50 million, an increase of 105.02% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error